- Trials with a EudraCT protocol (64)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
64 result(s) found for: Cost Benefit Analysis.
Displaying page 1 of 4.
EudraCT Number: 2015-003162-82 | Sponsor Protocol Number: 00171 | Start Date*: 2015-10-21 |
Sponsor Name:Raimo Tuuminen | ||
Full Title: treat-and-extend regimen (TER) in patients with diabetic macular edema | ||
Medical condition: Diabetic macular edema | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000364-15 | Sponsor Protocol Number: SUNRISE-CRC | Start Date*: 2019-09-11 |
Sponsor Name:VU University Medical Center, Department of Medical | ||
Full Title: A randomized phase II/III study of pulsatile high-dose sunitinib versus TAS-102 in patients with metastatic colorectal carcinoma (mCRC). | ||
Medical condition: Advanced colorectal tumors | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002479-33 | Sponsor Protocol Number: R2377 | Start Date*: 2020-03-02 | ||||||||||||||||||||||||||
Sponsor Name:Hull University Teaching Hospitals NHS Trust | ||||||||||||||||||||||||||||
Full Title: A parallel group, double-blind, randomised, placebo-controlled trial comparing the effectiveness and cost effectiveness of low dose oral modified release morphine versus placebo on patient-reported... | ||||||||||||||||||||||||||||
Medical condition: Chronic breathlessness due to cardiac, respiratory disease or cancer. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002319-25 | Sponsor Protocol Number: | Start Date*: 2012-11-19 |
Sponsor Name:University of Texas Health Science Center | ||
Full Title: A pilot, phase IIb, randomised, multicentre trial of Argatroban in combination with recombinant tissue plasminogen activator for acute stroke | ||
Medical condition: Ischemic Stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-002556-32 | Sponsor Protocol Number: ANTIC:6672 | Start Date*: 2013-09-05 | |||||||||||
Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust | |||||||||||||
Full Title: Antibiotic treatment for intermittent bladder catheterisation: A randomised controlled trial of once daily prophylaxis (The AnTIC study) | |||||||||||||
Medical condition: Recurrent urinary tract infection in people who use intermittent bladder catheterisation. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011637-27 | Sponsor Protocol Number: CHARTT-001 | Start Date*: 2010-08-24 |
Sponsor Name:Hull and East Yorkshire NHS Hospital Trust | ||
Full Title: Clopidogrel versus Aspirin in Chronic Heart Failure | ||
Medical condition: Heart Failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-003154-32 | Sponsor Protocol Number: N/A | Start Date*: 2017-09-18 |
Sponsor Name:University of Leeds | ||
Full Title: SPAARK: Study of Peri-Articular Anaesthetic for Replacement of the Knee. The clinical and cost effectiveness of peri-articular liposomal bupivacaine compared with bupivacaine hydrochloride alone fo... | ||
Medical condition: Local anaesthetic for patients undergoing knee replacement surgery for arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004075-41 | Sponsor Protocol Number: 2020-6941 | Start Date*: 2021-02-04 |
Sponsor Name:Radboudumc | ||
Full Title: Effectiveness of Somatostatin Analogues in patients with Gastric antral vascular ectasia and symptomatic gastrointestinal bleeding: SAGAVE-Pilot study | ||
Medical condition: Gastric Antral Vascular Ectasia (also known as watermelon stomach) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001392-22 | Sponsor Protocol Number: RC16_0467 | Start Date*: 2017-09-27 | |||||||||||
Sponsor Name:CHU de Nantes | |||||||||||||
Full Title: Randomized double-blind study on the benefit of spironolactone for treating acne of adult woman | |||||||||||||
Medical condition: Acne vulgaris of adult woman | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011445-13 | Sponsor Protocol Number: IJB-BGDO-2009-001 | Start Date*: 2009-11-26 |
Sponsor Name:Institut Jules Bordet-Université Libre de Bruxelles | ||
Full Title: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer | ||
Medical condition: Stage III colon adenocarcinoma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003630-33 | Sponsor Protocol Number: ERGO45359 | Start Date*: 2019-01-23 | |||||||||||
Sponsor Name:University of Southampton | |||||||||||||
Full Title: Spironolactone for Adult Female Acne: A pragmatic multicentre double-blind randomised superiority trial to investigate the clinical and cost-effectiveness of spironolactone for moderate or severe p... | |||||||||||||
Medical condition: Acne of sufficient severity to warrant treatment with oral antibiotics. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006111-62 | Sponsor Protocol Number: CRAD001JDE49 | Start Date*: 2012-07-11 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: A Phase IIIB, Multi-Center, Open Label Study For Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) in Combination Wi... | |||||||||||||
Medical condition: The trial aims to evaluate the efficacy, safety, quality of life and health resources in postmenopausal women with hormone receptor positive breast cancer progressing following prior therapy with N... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003591-37 | Sponsor Protocol Number: SPON846-10 | Start Date*: 2012-09-03 | |||||||||||
Sponsor Name:Cardiff University | |||||||||||||
Full Title: Children with Eczema Antibiotic Management Study (CREAM) | |||||||||||||
Medical condition: Atopic Eczema | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001769-27 | Sponsor Protocol Number: CHI0465 | Start Date*: 2008-09-29 |
Sponsor Name:Southampton University Hospital Trust | ||
Full Title: Microbiological assessment of prophylactic ciprofloxacin therapy for children with cystic fibrosis during viral respiratory viral infection to prevent Pseudomonas aeruginosa colonisation – a random... | ||
Medical condition: Cystic Fibrosis Specifically the trial will include children aged 2-14 years with a diagnosis of cystic fibrosis and not chronically infected with pseudomonas aeruginosa in their lungs. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019783-37 | Sponsor Protocol Number: MZ10-NETR-RadvanMartin | Start Date*: 2010-06-15 |
Sponsor Name:Hospital Trebic | ||
Full Title: Two doses of albumin after large paracentesis in cirrhotics with refractory ascites: a randomized study | ||
Medical condition: patients with decompensated liver cirrhosis and refractery ascites indicated for large /more then 5 L/ volume paracentesis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003590-10 | Sponsor Protocol Number: HM19/123658 | Start Date*: 2019-10-30 | ||||||||||||||||||||||||||
Sponsor Name:University of Leeds | ||||||||||||||||||||||||||||
Full Title: Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma: A phase III trial to compare standard and frailty-adjusted induction therapy with ixazomib, lena... | ||||||||||||||||||||||||||||
Medical condition: Newly diagnosed multiple myeloma | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001874-89 | Sponsor Protocol Number: ZKSJ0112_ARISS | Start Date*: 2019-02-25 | ||||||||||||||||
Sponsor Name:Friedrich-Schiller-Universität Jena | ||||||||||||||||||
Full Title: Randomised controlled multicentre study of albumin replacement therapy in septic shock | ||||||||||||||||||
Medical condition: Septic Shock | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-002435-42 | Sponsor Protocol Number: STH19290 | Start Date*: 2018-01-18 | |||||||||||||||||||||
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | |||||||||||||||||||||||
Full Title: DANTE: A randomised phase III trial to evaluate the Duration of ANti-PD1 monoclonal antibody Treatment in patients with metastatic mElanoma | |||||||||||||||||||||||
Medical condition: Advanced (unresectable stage III or stage IV (metastatic)) melanoma | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004013-13 | Sponsor Protocol Number: GS-US-313-0124 | Start Date*: 2013-10-31 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination with Rituximab for Previously Treated Indolent Non-Hodgkin Ly... | |||||||||||||
Medical condition: Indolent Non-Hodgkin Lymphomas •Follicular lymphoma •Small lymphocytic lymphoma •Lymphoplasmacytic lymphoma (with or without Waldenström macroglobulinemia) •Marginal zone lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Completed) SE (Prematurely Ended) ES (Completed) HU (Completed) CZ (Prematurely Ended) IT (Prematurely Ended) PT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-005120-16 | Sponsor Protocol Number: 62638 | Start Date*: 2018-11-02 | |||||||||||
Sponsor Name:Amsterdam UMC, Location VUmc | |||||||||||||
Full Title: Ulipristal versus standard surgical treatment in symptomatic uterine fibroids | |||||||||||||
Medical condition: Uterine fibroids are very common during reproductive years in women. Minimally invasive treatments are emerging. Myomectomy is the gold standard, preferably laparoscpically, because it removes the ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Restarted) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.